Taku Kobayashi Selected Research

Interleukins

11/2012	Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis.
2/2009	Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taku Kobayashi Research Topics

Disease

53	Ulcerative Colitis 04/2024 - 06/2008
25	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024 - 11/2008
24	Crohn Disease (Crohn's Disease) 04/2024 - 08/2009
19	Colitis 01/2023 - 11/2008
14	Inflammation (Inflammations) 10/2023 - 03/2010
7	Neoplasms (Cancer) 01/2024 - 01/2015
5	Infections 06/2023 - 01/2018
4	Necrosis 10/2023 - 01/2022
3	Hemorrhage 04/2024 - 11/2018
3	Leukopenia 01/2024 - 09/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 04/2018
3	Pathologic Constriction (Stenosis) 11/2023 - 06/2020
3	Injection Site Reaction 01/2022 - 01/2020
2	Alopecia (Baldness) 01/2024 - 09/2018
2	Arthralgia (Joint Pain) 06/2023 - 05/2018
2	Herpes Zoster 06/2023 - 01/2023
2	Fistula 01/2023 - 12/2017
2	Diarrhea 08/2022 - 01/2022
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 06/2020
2	Rheumatoid Arthritis 01/2022 - 11/2012
2	Ulcer 11/2018 - 10/2017
1	Bradycardia 04/2024
1	Hypertension (High Blood Pressure) 04/2024
1	Atrioventricular Block 04/2024
1	Abdominal Pain (Pain, Abdominal) 04/2024
1	Fibrosis (Cirrhosis) 11/2023
1	Opportunistic Infections (Opportunistic Infection) 06/2023
1	Nasopharyngitis 06/2023
1	Fatigue 01/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Genetic Risk Score 01/2022
1	Fever (Fevers) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Melanoma (Melanoma, Malignant) 06/2020
1	Skin Neoplasms (Skin Cancer) 06/2020

Drug/Important Bio-Agent (IBA)

13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2023 - 06/2008
9	Interleukin-10 (Interleukin 10)IBA 01/2019 - 03/2010
7	2-mercaptopurineIBA 01/2024 - 09/2018
7	Immunologic Factors (Immunomodulators)IBA 10/2023 - 02/2020
7	SteroidsIBA 10/2023 - 11/2010
6	Interleukin-23 (Interleukin 23)IBA 03/2024 - 06/2008
6	Infliximab (Remicade)FDA Link 09/2023 - 03/2016
6	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023 - 01/2017
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2012
6	Capsules (Microcapsules)IBA 04/2021 - 09/2014
5	mirikizumabIBA 04/2024 - 06/2023
5	Mesalamine (Mesalazine)FDA LinkGeneric 01/2023 - 01/2019
4	vedolizumabIBA 04/2024 - 01/2020
4	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2024 - 04/2005
4	Monoclonal AntibodiesIBA 03/2024 - 07/2021
4	Adalimumab (Humira)FDA Link 01/2021 - 10/2017
4	CytokinesIBA 01/2012 - 11/2008
3	Glycoproteins (Glycoprotein)IBA 01/2023 - 11/2012
3	Leucine (L-Leucine)FDA Link 01/2023 - 11/2012
3	Interleukin-12 (IL 12)IBA 07/2021 - 08/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 11/2021
2	Biosimilar PharmaceuticalsIBA 10/2023 - 10/2019
2	Tumor Necrosis Factor InhibitorsIBA 09/2023 - 08/2019
2	tofacitinibIBA 01/2023 - 07/2021
2	Janus Kinase InhibitorsIBA 01/2023 - 07/2021
2	Dextran SulfateIBA 01/2023 - 03/2010
2	C-Reactive ProteinIBA 08/2022 - 01/2022
2	Certolizumab Pegol FDA Link 01/2022 - 08/2019
2	TabletsIBA 07/2020 - 01/2019
2	Indigo Carmine (Indigo Blue)IBA 02/2020 - 01/2018
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019 - 11/2010
2	EnzymesIBA 09/2018 - 08/2009
2	AntigensIBA 01/2018 - 03/2017
2	Phosphotransferases (Kinase)IBA 04/2014 - 11/2010
2	Heme Oxygenase-1IBA 04/2013 - 05/2011
2	Carbon MonoxideIBA 04/2013 - 05/2011
2	InterleukinsIBA 11/2012 - 02/2009
2	Therapeutic UsesIBA 05/2011 - 11/2008
1	Sphingosine-1-Phosphate ReceptorsIBA 04/2024
1	IntegrinsIBA 04/2024
1	W 12IBA 03/2024
1	upadacitinibIBA 02/2024
1	Interleukin-18 (Interleukin 18)IBA 11/2023
1	Interleukin-17 (Interleukin 17)IBA 11/2023
1	golimumab FDA Link 03/2023
1	Phenobarbital (Luminal)FDA Link 01/2023
1	GLPG0634IBA 01/2023
1	Janus Kinase 1IBA 01/2023
1	Anion Exchange ResinsIBA 08/2022
1	AlbuminsIBA 08/2022
1	Bile Acids and Salts (Bile Acids)IBA 08/2022
1	colestimideIBA 08/2022
1	P-2 (P 2)IBA 01/2022
1	NucleotidesIBA 11/2021
1	Diphosphates (Pyrophosphates)IBA 11/2021
1	Ustekinumab (CNTO 1275)FDA Link 07/2021
1	AdrenomedullinIBA 01/2021
1	CT-P13IBA 10/2019

Therapy/Procedure

29	Therapeutics 04/2024 - 05/2014
3	Colectomy 01/2024 - 11/2010
3	Restorative Proctocolectomy 01/2023 - 05/2014
3	Remission Induction 01/2022 - 01/2017
1	Duration of Therapy 01/2022
1	Drug Tapering 07/2021